Menu visibility control

Video

Events

Startup Surgery

Most Recent

Need to Know

Ahti Heinla, co-founder of Starship Technologies, on how robots will transform the delivery space

Government & Policy

UK government to announce £17.3m boost for artificial intelligence and robotics

News

Top tech stats: Unpaid overtime, poor data usage and more

Press Releases

Software testing leader TestPlant appoints Dr. John Bates as CEO
CreditLadder appoints Proptech Expert Sheraz Dar as new CEO
Hermit: A Startup With New Ideas About Office Space

Cambridge-based Healx secures £1.5m Series A to combat rare diseases

medication
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

HealthTech startup Healx has secured a £1.5m Series A round from Amadeus Capital and Jonathan Milner, a healthcare entrepreneur.

The Cambridge-based firm, which uses machine learning and advanced data analytics, seeks to find new uses for existing drugs in an attempt to combat rare diseases.

Hermann Hauser, partner and co-founder of Amadeus Capital Partners, said: “Healx has taken advances in machine learning, data mining and analytics and combined them with deep pharma and life sciences expertise to address a growing need in the healthcare sector.

October funding roundup: UK tech investment tops £130m

“With huge pressure on R&D budgets, drug repositioning will be essential in the fight against rare diseases,” he added.

Healx’s technology platform matches potential treatments to rare conditions and patients. The company aims to complete its drug repurposing studies within six months.

Tim Guilliams, founder & CEO at Healx, commented: “Studies into rare medical conditions have long failed to receive adequate funding.”

The firm says it will use the money to expand its technology platform and accelerate the drug review process, in hope to find treatments to more illnesses.

“By repurposing existing drugs to combat rare diseases, Healx is able to find potential treatments at a fraction of the cost and in a much shorter timeframe than developing a new drug,” Guilliams concluded.

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

starship technologies

Ahti Heinla, co-founder of Starship Technologies, on how robots will transform the delivery space
posted 10 hours ago

robotics

UK government to announce £17.3m boost for artificial intelligence and robotics
posted 17 hours ago

top tech stats

Top tech stats: Unpaid overtime, poor data usage and more
posted on February 25, 2017

startup weekly (4)

Startup Weekly: Starling Bank’s hackathon, FoodTech awards & more
posted on February 24, 2017

happy workers

A happy workforce: The key to business success
posted on February 24, 2017

podcasting revolution

Here’s how your tech firm can exploit the podcasting revolution
posted on February 24, 2017